by Dr. Joseph Mercola, Childrens Health Defense:
- A preprint study posted April 3 reports high rates of infection with BA.1, BA.1.1 and BA.2 — variants of Omicron — among triple-jabbed health care workers. In all, the incidence rate among the triple-jabbed with one of these variants was 22%, and only 10% remained asymptomatic.
- March 29 the U.S. Food and Drug Administration (FDA) authorized a second booster (dose No. 4, for those taking Pfizer or Moderna) for adults over age 50, as well as a third booster (dose No. 5) for immunocompromised people aged 12 and older. The additional boosters are to be given four months after the last dose.
- The U.S. Centers for Disease Control and Prevention (CDC) is also recommending adults who have received two doses of Janssen’s viral vector DNA shot to get a third shot using either Pfizer or Moderna, despite there being no data on the safety or effectiveness of mixing the various shots.
- FDA authorized doses 4 and 5, without input from its expert voting panel, based on data showing the Moderna shot was only 11% effective and caused side effects in 40% of recipients, and the Pfizer shot was 30% effective and caused side effects in 80% of people.
- The lead author of that paper, Dr. Gili Regev-Yochay, an infectious disease specialist at Sheba Medical Center in Tel HaShomer, Israel, has publicly stated that “Not a third dose, not a fourth dose, not a fifth dose will do anything to stop infections [long-term].”
TRUTH LIVES on at https://sgtreport.tv/
That the mRNA-based COVID shot is not a real vaccine is evidenced by the sheer number of “boosters” required to keep COVID-19 at bay. When the injections were released at the beginning of 2021, the promises flowed.
Getting the two-dose regimen was said to be 95% effective and would keep you safe from serious infection. If everyone would just roll up their sleeves and get the jab, the pandemic would be over in no time.
By mid-July 2021, just over half the adult U.S. population had received the shot. (Specifically, 56% had received one dose, and 49% were fully vaccinated with two doses.)
Well, before the year was over, reality started setting in, as effectiveness waned far more rapidly than anyone expected. What’s worse, the shot actually increased the infectivity of the Delta variant, and toward the latter part of 2021, hospitals around the world were starting to fill up with “vaccinated” COVID patients.
A preprint study, posted April 3, also reports high rates of infection with BA.1, BA.1.1 and BA.2 — variants of Omicron — among triple-jabbed health care workers.
In all, the incidence rate among the triple-jabbed with one of these variants was 22%, and only 10% remained asymptomatic. As concluded by the authors:
“We report high incidence of omicron infections despite recent booster vaccination in triple vaccinated individuals. Vaccine-induced antibody titres seem to play a limited role in risk of omicron infection. High viral load and secretion of live virus for up to nine days may increase transmission in a triple vaccinated population.”
FDA authorizes fourth and fifth doses
In mid-August 2021 — just eight months into the COVID jab campaign — the U.S. Food and Drug Administration authorized the first booster (the third dose of mRNA), starting with the immunocompromised.
Then, March 29, the FDA cleared a second booster (dose No. 4, for those taking Pfizer or Moderna) for adults over age 50, as well as a third booster (dose No. 5!) for the immunocompromised aged 12 and older. The additional boosters are to be given four months after the last dose.
The U.S. Centers for Disease Control and Prevention is also recommending adults who have received two doses of Janssen’s viral vector DNA shot to get a third shot using either Pfizer or Moderna. This despite there being ZERO data on mixing the various shots.
So, in a little over one year, we’ve gone from “two mRNA jabs will ensure you won’t carry the virus or get sick or die of COVID” to “you need a booster every four months and you can still contract, transmit, get sick and die of COVID.” At this rate, we’re looking at three injections per year, and the fully-jabbed and boosted are still getting sick with COVID.
For example, we recently found out that 7 in 10 “vaccinated” CDC employees got breakthrough infections in Aug. 2021, and Princess Cruises reported an outbreak onboard the Ruby Princess in March, despite a 100% “vaccination” rate among both crew and passengers, plus proof of a negative COVID test prior to boarding. As noted by Robert F. Kennedy Jr. in the video above, “it’s time to follow the science.”
COVID policy has nothing to do with science
Remarkably, the FDA made the decision to approve another booster without convening its expert voting committee, as is the norm. As noted by Dr. Marty Makary in a Wall Street Journal op-ed:
“The Food and Drug Administration last week authorized Americans 50 and over to get a fourth COVID vaccine dose. Some of the FDA’s own experts disagree with the decision, but the agency simply ignored them.
“It will convene its advisory committee this Wednesday [April 6] to discuss future vaccine needs. That’s like having lawyers present arguments to a judge who’s already issued a verdict … Decisions like this only reinforce the perception that COVID policy is driven by groupthink and politics.”
Even Dr. Paul Offit, whose faith in vaccines is legendary, expressed surprise and dismay at the FDA’s decision to move forward without holding an open meeting to allow experts to comment on the data. He told CNBC:
“It’s just sort of fait accompli. So, is this the way it works? We talk endlessly about how we follow the science — it doesn’t seem to work out that way.”
Dr. Peter Hotez, another well-known vaccine pusher, has also expressed concern about the continued booster trend. He told CNBC that vaccine policy should not merely be based on keeping people out of the hospital, but should also seek to prevent COVID infection and “long COVID.”
He pointed out that the effectiveness of the third dose against hospitalization from Omicron infection has been shown to decline from 91% to 78% in just four months. “That gives me pause for concern that the boosters are not necessarily holding up as well as we’d like,” he said.
It is really hard to believe that both of these vaccine pushers are actually waking up and beginning to question the narrative.
FDA’s decision based on shockingly bad data
The FDA reportedly based its decision to authorize doses 4 and 5 on Israeli data posted on the preprint server medRxiv, February 15. What evidence was provided in this as yet non-peer-reviewed study that was compelling enough to circumvent the voting committee and public comment? According to the authors:
“Breakthrough infections were common, mostly very mild, yet, with high viral loads. Vaccine efficacy against infection was 30% and 11% for BNT162b2 [Pfizer] and mRNA1273 [Moderna], respectively. Local and systemic adverse reactions were reported in 80% and 40%, respectively.”
This is worth repeating. FDA authorized doses 4 and 5 based on data showing the Moderna shot was only 11% effective, and caused side effects in 40% of recipients, and the Pfizer shot was 30% effective and caused side effects in 80% of people. I know, you are probably shaking your head, saying, “What?!” That’s beyond astounding.
The FDA is charged with confirming that medical products are safe and effective. By authorizing the fourth and fifth COVID shots with abysmal effectiveness and sky-high adverse reaction rates they make it abundantly clear that they are a completely captured agency and have completely abrogated their responsibility for public health.
The lead author of that paper, Dr. Gili Regev-Yochay, and infectious disease specialist at Sheba Medical Center in Tel HaShomer, Israel, has even publicly stated that “Not a third dose, not a fourth dose, not a fifth dose will do anything to stop infections [long-term].”
Experts: we cannot boost our way out of the COVID pandemic
In an April 4 article, Forbes staff reporter Robert Hart writes:
“While a fourth dose appears to be beneficial at preventing serious illness in older or high-risk people, Dr. Amesh Adalja, a senior scholar at the Johns Hopkins Center for Health Security, told Forbes that repeated boosting is not ‘a viable strategy’ and it’s not clear that younger groups without high-risk health conditions ‘benefit much from even third doses.’”
Professor Deepta Bhattacharya, an immunologist at the University of Arizona, agrees, saying the current strategy is “not sustainable.” Similarly, Dr. Dan Barouch, a physician and vaccine researcher at Harvard Medical School, told Hart that getting a booster shot every three to six months is impractical for wealthy countries and “simply not possible” in poorer ones.